Loading...
•
Sep 30, 2023
AMN Healthcare Q3 2023 Earnings Report
AMN Healthcare announced Q3 2023 results with revenue of $853 million, GAAP EPS of $1.39, and adjusted EPS of $1.97.
Key Takeaways
AMN Healthcare's Q3 2023 revenue was $853.5 million, a 25% decrease year-over-year. Net income was $53 million, or $1.39 per diluted share, compared to $92 million, or $2.10 per diluted share, in Q3 2022. Adjusted diluted EPS was $1.97 compared to $2.57 in the same quarter last year.
Consolidated revenue for the quarter was $853.5 million, a 25% decrease from prior year.
Net income was $53 million (6.2% of revenue), or $1.39 per diluted share.
Adjusted diluted EPS in the third quarter was $1.97 compared with $2.57 in the same quarter a year ago.
In October 2023, AMN signed a definitive agreement to acquire MSDR for approximately $300 million.
AMN Healthcare
AMN Healthcare
AMN Healthcare Revenue by Segment
Revenue by Segment
Nurse and Allied Solutions Revenue
CapyFin.comPhysician and Leadership Solutions Revenue
CapyFin.comTechnology and Workforce Solutions Revenue
CapyFin.com Forward Guidance
Revenue in the fourth quarter of 2023 is expected to be 28-30% lower than prior year and 5-7% lower sequentially. Guidance does not include any contribution from the MSDR acquisition, which we expect to close later in the fourth quarter.
Challenges Ahead
- Nurse and Allied Solutions segment revenue is expected to be down 33-35% year over year.
- Physician and Leadership Solutions segment revenue is expected to be down 12-14% year over year.
- For the Technology and Workforce Solutions segment, we expect revenue to be approximately 18% lower year over year.
Revenue & Expenses
Visualization of income flow from segment revenue to net income